Search Results 421-430 of 14180 for akathisia

  1. Alzheimer's disease - Doctors and departments - Mayo Clinic

    Understand more about this brain disease that is the most common cause of dementia. Also learn about new tests and medicines.

  2. A Study of AG-946 in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS) - Mayo Clinic

    The purpose of phase 2a is to establish proof-of-concept (POC) for AG-946 in participants with lower-risk myelodysplastic syndromes (LR-MDS) and to evaluate the ...

  3. Publications - Amy S. Oxentenko, M.D. - Mayo Clinic

    Publications · Maida M, Ramai D, Mori Y, Dinis-Ribeiro M, Facciorusso A, Hassan C, and the AI-CORE (Artificial Intelligence COlorectal cancer Research) Working ...

  4. Alzheimer's disease - Doctors and departments - Mayo Clinic

    Understand more about this brain disease that is the most common cause of dementia. Also learn about new tests and medicines.

  5. Alzheimer's disease - Doctors and departments - Mayo Clinic

    Understand more about this brain disease that is the most common cause of dementia. Also learn about new tests and medicines.

  6. Movement disorders - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  7. Mayo Clinic

    ... . IMG-20461470. Home; cc-woman-handweights_mobile. Double your impact on cancer! Give Now. Make a gift before July 31 and it can be doubled in impact ...

  8. Childhood apraxia of speech - Doctors and departments - Mayo Clinic

    Mayo Clinic speech and language specialists (speech-language pathologists) and doctors trained in brain and nervous system conditions (neurologists) research ...

  9. Acetylcysteine (inhalation route) - Mayo Clinic

    Acetylcysteine is used for certain lung conditions when increased amounts of mucus make breathing difficult. Acetylcysteine liquefies (thins) or dissolves mucus ...

  10. A Study to Evaluate the Effectiveness and Safety of G10 in Subjects with Transthyretin Amyloid Cardiomyopathy - Mayo Clinic

    The purpose of this study is to evaluate AG10 800 mg compared to placebo in subjects with symptomatic Transthyretin Amyloid Cardiomyopathy (ATTR-CM).